2023 Autonomic Disorders Reading List

Reading List

Please click below to access the 2023 Autonomic Disorders reading list.

C-cert Activity Description

The Continuous Certification (C-cert) activities provide subspecialty learning and knowledge assessment to ensure that diplomates are staying up to date on the latest science, treatments, and therapeutics relating to their subspecialty. The annual activities include: 1) reading the subspecialty journal articles, and 2) taking and passing the 25-question online post-reading quiz to assess knowledge gained from the journal article content. 

Learning Objectives

• Accurately diagnose patients with autonomic dysfunction and autonomic failure, including disorders of orthostatic intolerance, syncope, neurogenic orthostatic hypotension, afferent baroreflex failure, autonomic neuropathies, and synucleinopathies
• Correctly incorporate testing modalities in the patient population to more quickly provide accurate diagnosis and prognosis to patients with autonomic dysfunction and failure
• Utilize treatment modalities in the patient population that is most likely to benefit from them, including orthostatic intolerance, orthostatic hypotension, syncope, and autonomic neuropathies

Core Competencies

• Medical Knowledge
• Patient Care
• Practice-Based Learning and Improvement

Continuing Medical Education (CME) Instructions

To claim CME credits, answer question 26 on the quiz to reflect the total time spent completing the required reading and online quiz. This question is not included in the scoring of the quiz. A passing score of 80% of higher is needed to meet C-cert requirements and receive CME credit. CME credit confirmation will be emailed within 24 hours of passing the quiz.

ACCME Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Academy of Neurology Institute (AANI) and United Council for Neurologic Subspecialties. The AANI is accredited by the ACCME to provide continuing medical education for physicians.

AMA Credit Designation Statement

The American Academy of Neurology Institute designates this enduring material for a maximum of 15 AMA PRA Category 1^TM credit(s). Physicians should claim only their credit commensurate with the extent of the participation in the activity.

ABPN Self-Assessment Designation Statement

The American Board of Psychiatry & Neurology (ABPN) has reviewed the UCNS Continuous Certification (C-cert) self-assessment activity and has approved the program as a part of a comprehensive self-assessment (SA) program, which is mandates by the American Board of Medical Specialties as a necessary component of maintenance of certification. The number of ABPN SA credits granted will equal the number of CME hours claimed for the activity. 

Disclosures

The UCNS complies with all standards and policies of the ACCME, including identification and resolution of all conflicts of interest prior to the educational activity being delivered to learners. Accordingly, UCNS  planners, authors, and staff comply with the UCNS’s Conflicts of Interest Policy. 

2023 C-cert Activity Planner Disclosures
All relevant financial relationships have been mitigated.

Autonomic Disorders Certification Examination Committee Contributors

Elizabeth Coon, MD, Chair, Mayo Clinic – Rochester 
Disclosures: Nothing to disclose.

Satish Raj, MD, Vice Chair, University of Calgary
Disclosures: Consultant to Lundbeck LLC, Theravance Biopharma, and Amneal Pharma related to neurogenic orthostatic hypotension; Consultant to Servier Affaires Medicales, Regeneron, and argenx; BV related to postural orthostatic tachycardia syndrome. Honoraria from Spire Learning and Medscape for developing CME materials on neurogenic orthostatic hypotension; DMSB Chair for a Phase 2 study of an irritable bowel syndrome medication for Arena Pharmaceuticals with compensation; Associate Editor, Autonomic Neurosciences (Elsevier); Peer Reviewed Research Grants from Canadian Institutes of Health Research (CIHR), Cummings School of Medicine, Dysautonomia International, and Stand Up To POTS; Past-President, American Autonomic Society.

Srikanth Muppidi, MD, Stanford Neuroscience Health Center
Disclosures: Advisory board meetings for Alexion, argenx, UCB pharma, Horizont Pharma.

Melissa M. Cortez, DO, University of Utah Health
Disclosures: Subpoenaed to provide an account of evaluation for a patient, including testimony about the diagnosis; compensated at a reasonable hourly rate; received grant funding from the NIH NINDS (K23 and R21), as well as the Amgen Early Investigator Award.

Elisabeth Golden, MD, UT Southwestern
Disclosures: Received research support (in the form of salary support) from the Ware Fund (nonprofit) 9/2020-3/2022.

Nathaniel Robbins, MD, Dartmouth-Hitchcock/Mary Hitchcock Memorial Hospital
Disclosures: Served as expert witness/consultant: HHS/DoJ VICP/dICP Kraft Davies LLC Vickery and Shepherd; received research support from Swigart Ethics Fellowship Diamond Endowment Fund Reeves Endowment Fund Ethnoinstitute.

Howard Snapper, MD, WellStar Medical Group
Disclosures: Nothing to disclose.

Kamal Shouman, MD, Mayo Clinic – Rochester 
Disclosures: Nothing to disclose.

Amanda Peltier, MD, Vanderbilt University Medical Center
Disclosures: Received compensation from Alnylam: advertising board; research grant from CSL Behring for an investigator-initiated study for $370K; served on ABPN neuromuscular exam committee, stopped in April 2022.

Gisela G. Chelimsky, MD, Virginia Commonwealth University
Disclosures: Owners of a teaching company, PainSTakers LLC. We have not received any compensation; Husband, advisor to Proctor and Gamble; Husband receives compensation for serving on scientific advisory board and as expert witness; received research support from NIDDK AHRQ; member of exam or review exam development committee for APP since July 2022.

Staff Contact

Bryan Hagerla, Continuous Certification Manager
Disclosures: Nothing to disclose.
[email protected]
(612) 928-6326